|
WO2004064837A1
|
|
Antibacterial fab i inhibitors
|
|
AU2003274927A8
|
|
Methods and reagents for preventing bacteremias
|
|
AU2003240545A8
|
|
Use of ramoplanin to treat diseases associated with the use of antibiotics
|
|
US2007021600A1
|
|
Nucleic acid and amino acid sequences relating to Enterococcus faecalis for diagnostics and therapeutics
|
|
US2004009583A1
|
|
Seal for microtiter plate and methods of use thereof
|
|
AU2002360273A1
|
|
Nucleotide and amino acid sequences relating to respiratory diseases and obesity
|
|
AU2002332742A1
|
|
Confirmation sequencing
|
|
AU2002368251A1
|
|
Characterizing nucleic acid and amino acid sequences in silico
|
|
IL158750D0
|
|
Reagents and methods for modulating dkk-mediated interactions
|
|
EP1483288A2
|
|
Hbm variants that modulate bone mass and lipid levels
|
|
AU2002307369A1
|
|
Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
|
|
AU2002252108A1
|
|
Plasmid for insertional mutagenesis in bacteria
|
|
AU2002252093A1
|
|
Method for the systematic discovery of genes and genes discovered thereby
|
|
US2002142336A1
|
|
Methods for determining a nucleotide at a specific location within a nucleic acid molecule
|
|
AU8678401A
|
|
Device for rapid dna sample processing with integrated liquid handling, thermocycling, and purification
|
|
AU8836001A
|
|
Genomics-assisted rapid identification of targets
|
|
AU2001269712A2
|
|
Regulating lipid levels via the ZMAXI or HBM gene
|
|
IL152654D0
|
|
Regulating lipid levels via the zmaxi or hbm gene
|
|
EP1317532A2
|
|
Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
|
|
EP1294943A2
|
|
RAPID DETERMINATION OF GENE STRUCTURE USING cDNA SEQUENCE
|
